The Biggest Challenges In Allogeneic Cell Therapy Manufacturing
Source: Entegris, Inc.
In this segment, our expert panelists cover the variability drivers for allogeneic cell therapies, the criteria or non-negotiables for a healthy donor, as well as the biggest challenges in batch-to-batch variation for allogeneic cell therapy manufacturing.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Entegris, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more